Losartan-based versus atenolol-based therapy in patients with hypertension and left ventricular hypertrophy: An economic evaluation of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study for Germany

被引：0
|
作者：
Krobot, K. J.
Carides, G. W.
Wagner, A.
Burke, T. A.
机构：
[1] MSD Sharp & Dohme GmbH, Haar, Germany
[2] Merck & Co Inc, Upper Gwynedd, PA USA
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63668-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A353 / A353
页数：1
相关论文
共 50 条
  • [1] An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands
    Boersma, Cornelis
    Carides, George W.
    Atthobari, Jarir
    Voors, Adriaan A.
    Postma, Maarten J.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (05) : 963 - 971
  • [2] Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    McInnes, G
    Burke, TA
    Carides, G
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2006, 20 (01) : 51 - 58
  • [3] Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    G McInnes
    T A Burke
    G Carides
    [J]. Journal of Human Hypertension, 2006, 20 : 51 - 58
  • [4] Regression of electrocardiographic left ventricular hypertrophy by Losartan versus atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Nieminen, MS
    Snapinn, S
    Harris, KE
    Aurup, P
    Edelman, JM
    Dahlöf, B
    [J]. CIRCULATION, 2003, 108 (06) : 684 - 690
  • [5] Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE) study
    Devereux, RB
    Lyle, PA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2311 - 2320
  • [6] Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
    Olsen, Michael Hecht
    Wachtell, Kristian
    Beevers, Gareth
    Dahlof, Bjorn
    de Simone, Giovanni
    Devereux, Richard B.
    de Faire, Ulf
    Fyhrquist, Frej
    Ibsen, Hans
    Kjeldsen, Sverre E.
    Lederballe-Pedersen, Ole
    Lindholm, Lars H.
    Lyle, Paulette A.
    Nieminen, Markku S.
    Omvik, Per
    Oparil, Suzanne
    Wedel, Hans
    [J]. JOURNAL OF HYPERTENSION, 2009, 27 (03) : 567 - 574
  • [7] Benefits of losartan compared to atenolol in stroke prevention among patients with hypertension and left ventricular hypertrophy: The Losartan intervention for endpoint reduction in hypertension (LIFE) Study
    Kizer, JR
    Dahlof, B
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Wachtell, K
    Snapinn, S
    Edelman, J
    [J]. CIRCULATION, 2003, 108 (17) : 601 - 602
  • [8] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    Devereux, RB
    Dahlöf, B
    Gerdts, E
    Boman, K
    Nieminen, MS
    Papademetriou, V
    Rokkedal, J
    Harris, KE
    Edelman, JM
    Wachtell, K
    [J]. CIRCULATION, 2004, 110 (11) : 1456 - 1462
  • [9] Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    Ruwald, Anne Christine H.
    Westergaard, Bo
    Sehestedt, Thomas
    Kjeldsen, Sverre E.
    Lindholm, Lars H.
    Wachtell, Kristian
    Devereux, Richard B.
    Ibsen, Hans
    Nieminen, Markku S.
    Dahlof, Bjorn
    Olsen, Michael H.
    [J]. JOURNAL OF HYPERTENSION, 2012, 30 (06) : 1252 - 1259
  • [10] Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study
    Os, Ingrid
    Franco, Veronica
    Kjeldsen, Sverre E.
    Manhem, Karin
    Devereux, Richard B.
    Gerdts, Eva
    Hille, Darcy A.
    Lyle, Paulette A.
    Okin, Peter M.
    Dahlof, Bjorn
    Oparil, Suzanne
    [J]. HYPERTENSION, 2008, 51 (04) : 1103 - 1108
12345